Related Experiment Videos
alpha-Melanocyte-stimulating hormone and acute renal failure
1Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, USA.
Current Opinion in Nephrology and Hypertension
|August 5, 1998
Summary
Alpha-melanocyte-stimulating hormone (MSH) is an anti-inflammatory cytokine that protects against kidney injury. This study shows alpha-MSH inhibits inflammation and renal failure, even when administered after injury.
Area of Science:
- Immunology
- Nephrology
- Endocrinology
Background:
- Alpha-melanocyte-stimulating hormone (MSH) is an endogenous anti-inflammatory cytokine.
- It is found at inflammation sites and produced in the pituitary and macrophages.
- Its effects are mediated by melanocortin receptors on immune and renal cells.
Purpose of the Study:
- To investigate the protective effects of alpha-MSH on ischemic acute renal failure.
- To explore the mechanisms by which alpha-MSH exerts its renal protective functions.
Main Methods:
- Administration of alpha-MSH to mice and rats following induced ischemic acute renal failure.
- Assessment of renal injury markers and inflammatory gene activation.
- Evaluation of alpha-MSH efficacy in the presence and absence of neutrophils.
Main Results:
- Alpha-MSH significantly inhibited ischemic acute renal failure in rodent models.
- Its administration was effective even when initiated 6 hours post-injury.
- Alpha-MSH inhibited the activation of genes involved in inflammatory and cytotoxic renal injury.
- Efficacy was observed even in neutrophil-deficient conditions, suggesting direct renal tubule action.
Conclusions:
- Alpha-MSH demonstrates potent protective effects against ischemic acute renal failure.
- It acts, at least in part, by modulating gene expression related to renal inflammation and injury.
- The findings suggest a direct role for alpha-MSH in renal tubule protection, independent of neutrophils.